South Korean Scientists Identify SHP Protein to Slow Osteoarthritis in Animal Models
Updated
Updated · SciTechDaily · May 16
South Korean Scientists Identify SHP Protein to Slow Osteoarthritis in Animal Models
2 articles · Updated · SciTechDaily · May 16
Nature Communications published a South Korean study identifying SHP, or NR0B2, as a protein that slows osteoarthritis progression by protecting cartilage in animal models.
SHP levels fell sharply as osteoarthritis advanced, and mice lacking the protein developed faster cartilage degeneration and more severe pain.
Mechanism tests showed SHP suppresses cartilage-destroying enzymes MMP-3 and MMP-13 by regulating the IKKβ/NF-κB signaling pathway.
A single viral-vector gene delivery of SHP into affected joints reduced cartilage damage, improved mobility and eased pain even after osteoarthritis had already developed.
The findings point beyond pain-only treatment toward disease-modifying therapies that could slow or prevent irreversible joint damage.
A Korean protein discovery promises an osteoarthritis cure. Can it outpace America's heavily funded race for a single-shot treatment?
Scientists can now reverse osteoarthritis in animals with one injection. How soon could this end joint replacement surgeries for good?
A newly found protein shuts down a master inflammation switch. Could this unlock cures for other diseases driven by chronic inflammation?
SHP (NR0B2) Protein Identified as Key Cartilage Protector: New Hope for Disease-Modifying Osteoarthritis Therapies
Overview
A South Korean research team made a major breakthrough in osteoarthritis by discovering the SHP protein as a crucial protector of cartilage. SHP works by inhibiting the IKKβ/NF-κB signaling pathway in chondrocytes, which reduces the production of destructive enzymes like MMP-3 and MMP-13. This action helps safeguard cartilage integrity. Animal studies showed that losing SHP speeds up osteoarthritis and causes more severe cartilage damage, while restoring SHP levels reduces both cartilage damage and pain. These findings offer new hope for disease-modifying treatments that target the root cause of osteoarthritis, not just its symptoms.